S-1 · primary offering
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 27 of GRI Bio, Inc.'s SEC filings and found 19 warrant series, 1 ATM program, 4 shelf registrations, 2 S-1 registrations and 1 completed offering on file for GRI. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 6, 2026.
Raise routes on file: active ATM + effective shelf · latest dilution event 126 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Jun 30, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2025
Proposed maximum
Shares registered
Issued 2025
Proposed maximum
Shares registered
Issued 2025
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2024
Total capacity
Sold to date
Issued 2024
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Issued 2023
Total capacity
Remaining
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z